Podcast: Share the Vaccine ‘Recipe’
When the Biden administration announced support for waiving COVID-19 vaccine patents last week, it was met with praise, relief, skepticism, and alarm by different groups—but surprise all around. Pharmaceutical giants have long fought efforts to have their intellectual property released to meet international needs. And they’ve backed it up with immense political muscle.




























